title: Sofosbuvir-based regimens against an "easy" villain: HCV genotype 2.
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Bari, Italy.
authors.forename: Giuseppe
authors.identifier: 0000-0003-0285-9524
authors.initials: G
authors.lastname: Bruno
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Bari, Italy.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Saracino
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Bari, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Milella
authors.affiliation: Clinic of Infectious Diseases, University of Bari, Bari, Italy.
authors.forename: Gioacchino
authors.initials: G
authors.lastname: Angarano
mesh_terms: D000998:Antiviral Agents; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus; D006526:Hepatitis C; D019698:Hepatitis C, Chronic; D006801:Humans; D012254:Ribavirin; D000069474:Sofosbuvir; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D000069474:Sofosbuvir